Loading clinical trials...
Loading clinical trials...
The objective of this post-approval registry is to provide additional real-world evidence of the performance of the OCS Heart System to preserve DBD and DCD donor hearts.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
TransMedics
NCT07415421 · Hyperparathyroidism, Kidney Transplantation Recipients
NCT07425782 · Acute Myeloid Leukemia, Consolidation Therapy, and more
NCT06472973 · Alcohol Associated Liver Disease, Liver Transplantation
NCT07524062 · Wound Healing, Surgical Wound Infection, and more
NCT04748770 · Kidney Transplant Access, Obese Patients, and more
Cedars Sinai
Los Angeles, California
Stanford University
Palo Alto, California
University of California San Francisco
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions